XML 110 R92.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation - Restricted Stock Activity (Details)
12 Months Ended
Jun. 30, 2021
$ / shares
shares
Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Shares Awarded, Exercised/Released (in shares) | shares (121,021)
Restricted Stock | Vested  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Shares Awarded, Beginning balance (in shares) | shares 218,604
Shares Awarded, Cancelled/Forfeited (in shares) | shares (125,486)
Shares Awarded, Ending balance (in shares) | shares 681,570
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted Average Grant Date Fair Value, Beginning balance (in US$ per share) | $ / shares $ 12.95
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | $ / shares 24.21
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ / shares 6.17
Weighted Average Grant Date Fair Value, Ending balance (in US$ per share) | $ / shares $ 10.47
Cash-Settled Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Shares Awarded, Beginning balance (in shares) | shares 0
Restricted stock granted (in shares) | shares 232,002
Shares Awarded, Exercised/Released (in shares) | shares 0
Shares Awarded, Cancelled/Forfeited (in shares) | shares (46,400)
Shares Awarded, Ending balance (in shares) | shares 185,602
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted Average Grant Date Fair Value, Beginning balance (in US$ per share) | $ / shares $ 0
Restricted stock granted, weighted average grant date fair value (in US$ per share) | $ / shares 4.31
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | $ / shares 0
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ / shares 4.31
Weighted Average Grant Date Fair Value, Ending balance (in US$ per share) | $ / shares $ 4.31
Performance-Based Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Shares Awarded, Beginning balance (in shares) | shares 81,337
Restricted stock granted (in shares) | shares 306,095
Shares Awarded, Exercised/Released (in shares) | shares (805)
Shares Awarded, Cancelled/Forfeited (in shares) | shares (32,161)
Shares Awarded, Ending balance (in shares) | shares 354,466
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted Average Grant Date Fair Value, Beginning balance (in US$ per share) | $ / shares $ 15.78
Restricted stock granted, weighted average grant date fair value (in US$ per share) | $ / shares 4.10
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share) | $ / shares 31.70
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share) | $ / shares 9.97
Weighted Average Grant Date Fair Value, Ending balance (in US$ per share) | $ / shares $ 6.06
Farmer Bros. Co. Amended and Restated 2007 Long-Term Incentive Plan | Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock granted (in shares) | shares 709,473
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock granted, weighted average grant date fair value (in US$ per share) | $ / shares $ 10.10